Lipoxygenase: an emerging target for stroke therapy

Neuroprotection as approach to stroke therapy has recently seen a revival of sorts, fueled in part by the continuing necessity to improve acute stroke care, and in part by the identification of novel drug targets. 12/15- Lipoxygenase (12/15-LOX), one of the key enzymes of the arachidonic acid cascad...

Full description

Saved in:
Bibliographic Details
Published inCNS & neurological disorders drug targets Vol. 12; no. 2; p. 191
Main Author van Leyen, Klaus
Format Journal Article
LanguageEnglish
Published United Arab Emirates 01.03.2013
Subjects
Online AccessGet more information
ISSN1996-3181
DOI10.2174/18715273112119990053

Cover

Loading…
Abstract Neuroprotection as approach to stroke therapy has recently seen a revival of sorts, fueled in part by the continuing necessity to improve acute stroke care, and in part by the identification of novel drug targets. 12/15- Lipoxygenase (12/15-LOX), one of the key enzymes of the arachidonic acid cascade, contributes to both neuronal cell death and vascular injury. Inhibition of 12/15-LOX may thus provide multifactorial protection against ischemic injury. Targeting 12/15-LOX and related eicosanoid pathways is the subject of this brief review.
AbstractList Neuroprotection as approach to stroke therapy has recently seen a revival of sorts, fueled in part by the continuing necessity to improve acute stroke care, and in part by the identification of novel drug targets. 12/15- Lipoxygenase (12/15-LOX), one of the key enzymes of the arachidonic acid cascade, contributes to both neuronal cell death and vascular injury. Inhibition of 12/15-LOX may thus provide multifactorial protection against ischemic injury. Targeting 12/15-LOX and related eicosanoid pathways is the subject of this brief review.
Author van Leyen, Klaus
Author_xml – sequence: 1
  givenname: Klaus
  surname: van Leyen
  fullname: van Leyen, Klaus
  email: klaus_vanleyen@hms.harvard.edu
  organization: Neuroprotection Research Laboratory, Department of Radiology, Massachusetts General Hospital, 149 13th St., R. 2401, Charlestown, MA 02129, USA. klaus_vanleyen@hms.harvard.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23394536$$D View this record in MEDLINE/PubMed
BookMark eNo1jstKxTAURYMo3of-gUh-oJqT07ycycUXFJzo-JImp7Vq05JWsH_vBXW012Cx2Bt2nIZEjF2AuJJgymuwBpQ0CCABnHNCKDxi6wPqAsHCim2m6V2IUiOYU7aSiK5UqNcMq24cvpeWkp_ohvvEqafcdqnls88tzbwZMp_mPHwQn98o-3E5YyeN_5zo_G-37PX-7mX3WFTPD0-726qolVZzEQVYFzXIEGIsPdZOS0MeyQo0FEOtQIXSBRISGq0D1Q3oSDZY7yMe5C27_O2OX3VPcT_mrvd52f-_lz_eXUfs
CitedBy_id crossref_primary_10_1007_s00011_023_01770_8
crossref_primary_10_1007_s12975_016_0509_z
crossref_primary_10_1080_00207454_2019_1645142
crossref_primary_10_1038_s41598_020_69831_0
crossref_primary_10_1021_acs_jmedchem_8b01987
crossref_primary_10_3390_jcm6020022
crossref_primary_10_1080_26395940_2023_2292104
crossref_primary_10_31857_S1234567824080111
crossref_primary_10_1016_j_expneurol_2018_11_010
crossref_primary_10_1159_000350230
crossref_primary_10_1002_anie_202418291
crossref_primary_10_1016_j_bmc_2016_08_063
crossref_primary_10_1021_acsomega_7b01622
crossref_primary_10_1248_bpb_b23_00793
crossref_primary_10_1016_j_neuroscience_2017_07_015
crossref_primary_10_1002_chem_202402279
crossref_primary_10_1016_j_arres_2021_100023
crossref_primary_10_1016_j_ejmech_2016_07_010
crossref_primary_10_1002_bmc_5614
crossref_primary_10_3390_metabo11080498
crossref_primary_10_1134_S0021364024600460
crossref_primary_10_1016_j_bbalip_2016_11_008
crossref_primary_10_1080_14728222_2024_2446319
crossref_primary_10_2319_103123_730_1
crossref_primary_10_1016_j_jff_2022_105197
crossref_primary_10_1002_anie_201606876
crossref_primary_10_1038_jcbfm_2015_169
crossref_primary_10_1016_j_bioorg_2019_01_071
crossref_primary_10_1016_j_bbalip_2014_10_002
crossref_primary_10_1016_j_bmc_2016_01_042
crossref_primary_10_1016_j_jmgm_2015_12_001
crossref_primary_10_1016_j_redox_2015_08_006
crossref_primary_10_1021_jm401915r
crossref_primary_10_1080_1028415X_2017_1347373
crossref_primary_10_1002_ange_201606876
crossref_primary_10_1002_ange_202418291
crossref_primary_10_1016_j_gene_2015_07_073
crossref_primary_10_1016_j_biopha_2020_110151
crossref_primary_10_3390_molecules23071621
crossref_primary_10_1111_jnc_15308
crossref_primary_10_1161_STROKEAHA_116_014790
crossref_primary_10_1248_yakushi_23_00207
crossref_primary_10_3390_molecules26165001
crossref_primary_10_3389_fneur_2022_821082
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.2174/18715273112119990053
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1996-3181
ExternalDocumentID 23394536
Genre Journal Article
Review
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: R01 NS069939
– fundername: NINDS NIH HHS
  grantid: R01 NS049430
– fundername: NINDS NIH HHS
  grantid: R01NS069939
– fundername: NINDS NIH HHS
  grantid: R01NS049430
GroupedDBID ---
.5.
0R~
29B
36B
4.4
5GY
AAEGP
ABEEF
ABVDF
ACGFS
ACITR
AFUQM
AGJNZ
ALMA_UNASSIGNED_HOLDINGS
ANTIV
C1A
CGR
CS3
CUY
CVF
EBS
ECM
EIF
EJD
F5P
GH2
HZ~
IPNFZ
KCGFV
NPM
O9-
RIG
ID FETCH-LOGICAL-b565t-d0189d612ccdd4a3b9627ea3e8037edcb515c49ce021f66cebf16de8c8aad3962
IngestDate Thu May 23 23:18:31 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-b565t-d0189d612ccdd4a3b9627ea3e8037edcb515c49ce021f66cebf16de8c8aad3962
OpenAccessLink http://www.eurekaselect.com/article/50425
PMID 23394536
ParticipantIDs pubmed_primary_23394536
PublicationCentury 2000
PublicationDate 2013-03-01
PublicationDateYYYYMMDD 2013-03-01
PublicationDate_xml – month: 03
  year: 2013
  text: 2013-03-01
  day: 01
PublicationDecade 2010
PublicationPlace United Arab Emirates
PublicationPlace_xml – name: United Arab Emirates
PublicationTitle CNS & neurological disorders drug targets
PublicationTitleAlternate CNS Neurol Disord Drug Targets
PublicationYear 2013
References 21353711 - Trends Neurosci. 2011 Apr;34(4):198-209
12395100 - Neuroreport. 2002 Oct 28;13(15):1963-6
18840431 - Exp Eye Res. 2009 Feb;88(2):133-9
18309145 - Stroke. 2008 Apr;39(4):1389-91
12521597 - Free Radic Biol Med. 2003 Jan 15;34(2):145-69
19091170 - Curr Cardiol Rep. 2009 Jan;11(1):12-20
18323512 - Stroke. 2008 Apr;39(4):1109-14
19853588 - Brain Res. 2010 Jan 11;1307:149-57
16443152 - Free Radic Biol Med. 2006 Feb 1;40(3):376-87
9759730 - Nature. 1998 Sep 24;395(6700):392-5
17942241 - Neuroscience. 2007 Dec 12;150(3):585-91
16282974 - Nat Genet. 2006 Jan;38(1):68-74
20689558 - Cell Death Differ. 2011 Feb;18(2):282-92
20670828 - Neuron. 2010 Jul 29;67(2):181-98
17960827 - J Neurosci Res. 2008 Mar;86(4):904-9
10657944 - Am J Respir Cell Mol Biol. 2000 Feb;22(2):226-34
20138164 - Brain Res. 2010 Apr 6;1323:174-83
9854309 - Trends Cell Biol. 1998 Nov;8(11):436
15686484 - J Neurochem. 2005 Feb;92(4):824-30
17687131 - N Engl J Med. 2007 Aug 9;357(6):562-71
16500106 - Bioorg Med Chem. 2006 Jun 15;14(12):4295-301
21957234 - J Neurosci. 2011 Sep 28;31(39):13710-21
11740205 - J Cereb Blood Flow Metab. 2001 Dec;21(12):1436-41
15853750 - Curr Drug Targets Cardiovasc Haematol Disord. 2005 Apr;5(2):177-84
12125346 - Methods Enzymol. 2002;352:183-90
23192915 - Ann Neurol. 2013 Jan;73(1):129-35
9445321 - Stroke. 1998 Jan;29(1):12-7
16005201 - Prostaglandins Leukot Essent Fatty Acids. 2005 Sep-Oct;73(3-4):141-62
15033436 - Brain Res. 2004 Apr 9;1004(1-2):198-202
20801095 - Arch Biochem Biophys. 2010 Nov 15;503(2):161-74
10446122 - J Biol Chem. 1999 Aug 20;274(34):23679-82
14770184 - Nat Genet. 2004 Mar;36(3):233-9
18233953 - Annu Rev Pathol. 2008;3:279-312
12194501 - Neuroscientist. 2002 Aug;8(4):323-34
20357438 - Cerebrovasc Dis. 2010;29(6):528-37
15487674 - Sci Am. 2004 Oct;291(4):82-9
10560610 - Prostaglandins Other Lipid Mediat. 1999 Oct;58(2-4):65-75
11231012 - FEBS Lett. 2001 Jan 26;489(1):51-4
15086555 - J Invest Dermatol. 2004 Mar;122(3):691-8
18308347 - Neuropharmacology. 2008 Sep;55(3):363-89
15637312 - Stroke. 2005 Feb;36(2):182-5
21423332 - Transl Stroke Res. 2011 Mar;2(1):33-41
11158633 - Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1294-9
16923160 - J Neurochem. 2006 Sep;98(5):1474-86
18635843 - Stroke. 2008 Sep;39(9):2538-43
663662 - Science. 1978 Jul 28;201(4353):358-60
14672754 - Life Sci. 2004 Jan 9;74(8):969-85
17622306 - Mol Med. 2007 Jul-Aug;13(7-8):350-5
19737346 - J Neurochem. 2009 Nov;111(3):882-9
20059330 - Annu Rev Med. 2010;61:17-33
2180770 - FASEB J. 1990 Apr 1;4(6):1624-33
18384889 - Trends Pharmacol Sci. 2008 May;29(5):268-75
7903353 - J Neurochem. 1994 Jan;62(1):376-9
21719775 - Stroke. 2011 Aug;42(8):2308-14
18202310 - Stroke. 2008 Feb;39(2):521-2
15910986 - J Neurosci Methods. 2005 Jun 15;144(2):257-63
17826100 - Bioorg Med Chem. 2007 Nov 15;15(22):6900-8
21356152 - Expert Rev Mol Med. 2011;13:e7
18202309 - Stroke. 2008 Feb;39(2):523-4
9403693 - Nature. 1997 Dec 11;390(6660):622-5
22709986 - Neurobiol Dis. 2012 Oct;48(1):58-65
19542051 - Stroke. 2009 Sep;40(9):3121-6
17167069 - FASEB J. 2007 Mar;21(3):743-53
20068575 - J Cereb Blood Flow Metab. 2010 Jun;30(6):1157-67
6318 - FEBS Lett. 1975 Dec 1;60(1):149-52
21867913 - Chem Biol. 2011 Aug 26;18(8):976-87
14698463 - Neurosci Lett. 2004 Jan 9;354(2):163-5
20368741 - Nat Rev Neurol. 2010 May;6(5):256-65
12432925 - Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:303-12
9160751 - Cell. 1997 May 16;89(4):597-606
17053180 - Stroke. 2006 Dec;37(12):3014-8
6719118 - Science. 1984 May 25;224(4651):886-9
17272759 - Stroke. 2007 Mar;38(3):1063-8
15637315 - Stroke. 2005 Feb;36(2):189-92
21673716 - J Cereb Blood Flow Metab. 2011 Nov;31(11):2218-30
9414270 - Blood. 1998 Jan 1;91(1):64-74
22155783 - Mol Pharmacol. 2012 Mar;81(3):420-30
3087141 - Adv Enzymol Relat Areas Mol Biol. 1986;58:191-272
22700906 - Science. 2012 Jun 15;336(6087):1386-7
21427623 - J Trauma. 2011 Nov;71(5):1211-8
15180492 - Curr Drug Metab. 2004 Jun;5(3):225-34
15450084 - Eur J Neurosci. 2004 Oct;20(8):2049-58
5473492 - Biochim Biophys Acta. 1970 Oct 6;218(1):1-10
2834836 - Stroke. 1988 Apr;19(4):480-5
18549870 - Am J Cardiol. 2008 Jun 16;101(12A):34F-40F
12204769 - Life Sci. 2002 Sep 20;71(18):2105-17
20494126 - Biochem Biophys Res Commun. 2010 May 21;396(1):135-9
9473716 - Brain Res Mol Brain Res. 1998 Jan;53(1-2):333-8
11526430 - Cell Death Differ. 2001 Aug;8(8):776-84
10432118 - Nature. 1999 Jul 22;400(6742):378-82
21838667 - Cardiovasc Hematol Agents Med Chem. 2011 Jul 1;9(3):154-64
21620406 - Atherosclerosis. 2011 Sep;218(1):181-7
20640551 - Age (Dordr). 2010 Sep;32(3):271-82
8683259 - J Neurosurg. 1996 Jul;85(1):112-6
11498518 - Br J Pharmacol. 2001 Aug;133(8):1323-9
12909283 - Brain Res Bull. 2003 Aug 30;61(4):399-406
22074807 - Neurobiol Aging. 2012 Mar;33(3):629.e1-3
16480270 - J Med Chem. 2006 Feb 23;49(4):1356-63
22542947 - Exp Neurol. 2012 Jul;236(1):122-30
1720576 - Stroke. 1991 Dec;22(12):1548-53
11207368 - Cell. 2001 Jan 26;104(2):281-90
6309072 - Ann Neurol. 1983 Jun;13(6):625-32
12917400 - J Biol Chem. 2003 Oct 31;278(44):43508-15
20157789 - Mol Neurobiol. 2010 Jun;41(2-3):172-9
16453316 - Ann Neurol. 2006 Mar;59(3):467-77
18439837 - Pharmacol Res. 2008 Apr;57(4):266-73
19840779 - Brain Res. 2010 Jan 11;1307:22-7
20673332 - J Neuroinflammation. 2010;7:42
16834755 - CNS Drug Rev. 2006 Spring;12(1):9-20
19422397 - Br J Pharmacol. 2009 Oct;158(4):972-81
18202308 - Stroke. 2008 Feb;39(2):525
22356734 - Antioxid Redox Signal. 2012 Sep 1;17(5):719-32
9292733 - Neuron. 1997 Aug;19(2):453-63
20868723 - Biochimie. 2011 Jan;93(1):46-51
18545259 - J Cereb Blood Flow Metab. 2008 Oct;28(10):1686-96
16166580 - Stroke. 2005 Oct;36(10):2258-64
12923200 - J Biol Chem. 2003 Oct 31;278(44):43807-17
18762024 - Cell Metab. 2008 Sep;8(3):237-48
17261713 - Stroke. 2007 Feb;38(2 Suppl):674-6
17608719 - FEBS J. 2007 Jul;274(14):3503-12
21835339 - Neuron. 2011 Aug 11;71(3):406-24
20229265 - Pflugers Arch. 2010 Jul;460(2):525-42
19808012 - Prostaglandins Other Lipid Mediat. 2010 Apr;91(3-4):104-12
References_xml – reference: 6318 - FEBS Lett. 1975 Dec 1;60(1):149-52
– reference: 9759730 - Nature. 1998 Sep 24;395(6700):392-5
– reference: 22356734 - Antioxid Redox Signal. 2012 Sep 1;17(5):719-32
– reference: 1720576 - Stroke. 1991 Dec;22(12):1548-53
– reference: 17826100 - Bioorg Med Chem. 2007 Nov 15;15(22):6900-8
– reference: 9414270 - Blood. 1998 Jan 1;91(1):64-74
– reference: 19840779 - Brain Res. 2010 Jan 11;1307:22-7
– reference: 15910986 - J Neurosci Methods. 2005 Jun 15;144(2):257-63
– reference: 15086555 - J Invest Dermatol. 2004 Mar;122(3):691-8
– reference: 19422397 - Br J Pharmacol. 2009 Oct;158(4):972-81
– reference: 16923160 - J Neurochem. 2006 Sep;98(5):1474-86
– reference: 12432925 - Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:303-12
– reference: 20059330 - Annu Rev Med. 2010;61:17-33
– reference: 16834755 - CNS Drug Rev. 2006 Spring;12(1):9-20
– reference: 18384889 - Trends Pharmacol Sci. 2008 May;29(5):268-75
– reference: 15033436 - Brain Res. 2004 Apr 9;1004(1-2):198-202
– reference: 20157789 - Mol Neurobiol. 2010 Jun;41(2-3):172-9
– reference: 8683259 - J Neurosurg. 1996 Jul;85(1):112-6
– reference: 12194501 - Neuroscientist. 2002 Aug;8(4):323-34
– reference: 20801095 - Arch Biochem Biophys. 2010 Nov 15;503(2):161-74
– reference: 19542051 - Stroke. 2009 Sep;40(9):3121-6
– reference: 663662 - Science. 1978 Jul 28;201(4353):358-60
– reference: 21427623 - J Trauma. 2011 Nov;71(5):1211-8
– reference: 6309072 - Ann Neurol. 1983 Jun;13(6):625-32
– reference: 10657944 - Am J Respir Cell Mol Biol. 2000 Feb;22(2):226-34
– reference: 16500106 - Bioorg Med Chem. 2006 Jun 15;14(12):4295-301
– reference: 11740205 - J Cereb Blood Flow Metab. 2001 Dec;21(12):1436-41
– reference: 15637315 - Stroke. 2005 Feb;36(2):189-92
– reference: 18233953 - Annu Rev Pathol. 2008;3:279-312
– reference: 9403693 - Nature. 1997 Dec 11;390(6660):622-5
– reference: 22074807 - Neurobiol Aging. 2012 Mar;33(3):629.e1-3
– reference: 18202308 - Stroke. 2008 Feb;39(2):525
– reference: 15487674 - Sci Am. 2004 Oct;291(4):82-9
– reference: 2834836 - Stroke. 1988 Apr;19(4):480-5
– reference: 9292733 - Neuron. 1997 Aug;19(2):453-63
– reference: 15450084 - Eur J Neurosci. 2004 Oct;20(8):2049-58
– reference: 7903353 - J Neurochem. 1994 Jan;62(1):376-9
– reference: 10560610 - Prostaglandins Other Lipid Mediat. 1999 Oct;58(2-4):65-75
– reference: 14770184 - Nat Genet. 2004 Mar;36(3):233-9
– reference: 17053180 - Stroke. 2006 Dec;37(12):3014-8
– reference: 21838667 - Cardiovasc Hematol Agents Med Chem. 2011 Jul 1;9(3):154-64
– reference: 10432118 - Nature. 1999 Jul 22;400(6742):378-82
– reference: 9473716 - Brain Res Mol Brain Res. 1998 Jan;53(1-2):333-8
– reference: 21719775 - Stroke. 2011 Aug;42(8):2308-14
– reference: 23192915 - Ann Neurol. 2013 Jan;73(1):129-35
– reference: 12521597 - Free Radic Biol Med. 2003 Jan 15;34(2):145-69
– reference: 20640551 - Age (Dordr). 2010 Sep;32(3):271-82
– reference: 16453316 - Ann Neurol. 2006 Mar;59(3):467-77
– reference: 18323512 - Stroke. 2008 Apr;39(4):1109-14
– reference: 21423332 - Transl Stroke Res. 2011 Mar;2(1):33-41
– reference: 11158633 - Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1294-9
– reference: 12917400 - J Biol Chem. 2003 Oct 31;278(44):43508-15
– reference: 22155783 - Mol Pharmacol. 2012 Mar;81(3):420-30
– reference: 20229265 - Pflugers Arch. 2010 Jul;460(2):525-42
– reference: 18840431 - Exp Eye Res. 2009 Feb;88(2):133-9
– reference: 9445321 - Stroke. 1998 Jan;29(1):12-7
– reference: 12923200 - J Biol Chem. 2003 Oct 31;278(44):43807-17
– reference: 22700906 - Science. 2012 Jun 15;336(6087):1386-7
– reference: 17608719 - FEBS J. 2007 Jul;274(14):3503-12
– reference: 16480270 - J Med Chem. 2006 Feb 23;49(4):1356-63
– reference: 18202310 - Stroke. 2008 Feb;39(2):521-2
– reference: 17272759 - Stroke. 2007 Mar;38(3):1063-8
– reference: 17687131 - N Engl J Med. 2007 Aug 9;357(6):562-71
– reference: 21353711 - Trends Neurosci. 2011 Apr;34(4):198-209
– reference: 20368741 - Nat Rev Neurol. 2010 May;6(5):256-65
– reference: 18635843 - Stroke. 2008 Sep;39(9):2538-43
– reference: 12125346 - Methods Enzymol. 2002;352:183-90
– reference: 15637312 - Stroke. 2005 Feb;36(2):182-5
– reference: 18308347 - Neuropharmacology. 2008 Sep;55(3):363-89
– reference: 17960827 - J Neurosci Res. 2008 Mar;86(4):904-9
– reference: 11526430 - Cell Death Differ. 2001 Aug;8(8):776-84
– reference: 20068575 - J Cereb Blood Flow Metab. 2010 Jun;30(6):1157-67
– reference: 20357438 - Cerebrovasc Dis. 2010;29(6):528-37
– reference: 17622306 - Mol Med. 2007 Jul-Aug;13(7-8):350-5
– reference: 21356152 - Expert Rev Mol Med. 2011;13:e7
– reference: 18439837 - Pharmacol Res. 2008 Apr;57(4):266-73
– reference: 20673332 - J Neuroinflammation. 2010;7:42
– reference: 11231012 - FEBS Lett. 2001 Jan 26;489(1):51-4
– reference: 20670828 - Neuron. 2010 Jul 29;67(2):181-98
– reference: 18762024 - Cell Metab. 2008 Sep;8(3):237-48
– reference: 15853750 - Curr Drug Targets Cardiovasc Haematol Disord. 2005 Apr;5(2):177-84
– reference: 2180770 - FASEB J. 1990 Apr 1;4(6):1624-33
– reference: 21673716 - J Cereb Blood Flow Metab. 2011 Nov;31(11):2218-30
– reference: 17261713 - Stroke. 2007 Feb;38(2 Suppl):674-6
– reference: 20138164 - Brain Res. 2010 Apr 6;1323:174-83
– reference: 19091170 - Curr Cardiol Rep. 2009 Jan;11(1):12-20
– reference: 21620406 - Atherosclerosis. 2011 Sep;218(1):181-7
– reference: 20868723 - Biochimie. 2011 Jan;93(1):46-51
– reference: 15180492 - Curr Drug Metab. 2004 Jun;5(3):225-34
– reference: 17167069 - FASEB J. 2007 Mar;21(3):743-53
– reference: 11498518 - Br J Pharmacol. 2001 Aug;133(8):1323-9
– reference: 17942241 - Neuroscience. 2007 Dec 12;150(3):585-91
– reference: 15686484 - J Neurochem. 2005 Feb;92(4):824-30
– reference: 16166580 - Stroke. 2005 Oct;36(10):2258-64
– reference: 9854309 - Trends Cell Biol. 1998 Nov;8(11):436
– reference: 10446122 - J Biol Chem. 1999 Aug 20;274(34):23679-82
– reference: 20494126 - Biochem Biophys Res Commun. 2010 May 21;396(1):135-9
– reference: 19853588 - Brain Res. 2010 Jan 11;1307:149-57
– reference: 9160751 - Cell. 1997 May 16;89(4):597-606
– reference: 22542947 - Exp Neurol. 2012 Jul;236(1):122-30
– reference: 6719118 - Science. 1984 May 25;224(4651):886-9
– reference: 21835339 - Neuron. 2011 Aug 11;71(3):406-24
– reference: 16282974 - Nat Genet. 2006 Jan;38(1):68-74
– reference: 19808012 - Prostaglandins Other Lipid Mediat. 2010 Apr;91(3-4):104-12
– reference: 11207368 - Cell. 2001 Jan 26;104(2):281-90
– reference: 14698463 - Neurosci Lett. 2004 Jan 9;354(2):163-5
– reference: 22709986 - Neurobiol Dis. 2012 Oct;48(1):58-65
– reference: 12204769 - Life Sci. 2002 Sep 20;71(18):2105-17
– reference: 12909283 - Brain Res Bull. 2003 Aug 30;61(4):399-406
– reference: 21867913 - Chem Biol. 2011 Aug 26;18(8):976-87
– reference: 18545259 - J Cereb Blood Flow Metab. 2008 Oct;28(10):1686-96
– reference: 20689558 - Cell Death Differ. 2011 Feb;18(2):282-92
– reference: 16443152 - Free Radic Biol Med. 2006 Feb 1;40(3):376-87
– reference: 3087141 - Adv Enzymol Relat Areas Mol Biol. 1986;58:191-272
– reference: 18549870 - Am J Cardiol. 2008 Jun 16;101(12A):34F-40F
– reference: 19737346 - J Neurochem. 2009 Nov;111(3):882-9
– reference: 18202309 - Stroke. 2008 Feb;39(2):523-4
– reference: 14672754 - Life Sci. 2004 Jan 9;74(8):969-85
– reference: 21957234 - J Neurosci. 2011 Sep 28;31(39):13710-21
– reference: 18309145 - Stroke. 2008 Apr;39(4):1389-91
– reference: 12395100 - Neuroreport. 2002 Oct 28;13(15):1963-6
– reference: 16005201 - Prostaglandins Leukot Essent Fatty Acids. 2005 Sep-Oct;73(3-4):141-62
– reference: 5473492 - Biochim Biophys Acta. 1970 Oct 6;218(1):1-10
SSID ssj0046317
Score 2.217289
SecondaryResourceType review_article
Snippet Neuroprotection as approach to stroke therapy has recently seen a revival of sorts, fueled in part by the continuing necessity to improve acute stroke care,...
SourceID pubmed
SourceType Index Database
StartPage 191
SubjectTerms Animals
Arachidonic Acid - metabolism
Enzyme Inhibitors - therapeutic use
Humans
Lipoxygenase - metabolism
Models, Biological
Stroke - drug therapy
Stroke - enzymology
Stroke - pathology
Title Lipoxygenase: an emerging target for stroke therapy
URI https://www.ncbi.nlm.nih.gov/pubmed/23394536
Volume 12
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1LS8QwEMeDj4sX8f2WHGQvbtc-0mzrTURZfOFhF7xJHlMQtbu4FVw_vZOkdbuLinoppSkh9NdMZkLmP4QcCCZ90AHzJIsTDFBi7QkBocd56EsWgGTKbOhf3_BOj13cxXfjwok2u6SQLfX-ZV7Jf6jiM-RqsmT_QPazU3yA98gXr0gYr79ifPUw6L-NsFm4FHOcqybf19Ydcke87SnCYfHSf4TDoiYgUGkT3Lgw3qpaVlZQl4Kcw0P98lp19Ol62zq_MHLW6vJJTG4cmCIO1cmpFjhjZw4g45wOJqxhWKMe1kxb4KpqTZtcE9KY6B8DL6PlFljJOFzifKcBXKMweLYYwihKWexUT35unRLCrppmySyGBKbGqdmYcYsu4-gHucxIM6Cjr4ZjdJ_LLqZiCOtLdJfIYhkE0BNHdJnMQL5CGrdORXzUpN1xUtywSRv0dqwvPlolUR37MRU5raBTx4oidOqg0xL6Gumdn3VPO15Z-8KT6GIXnvaDJNXofiqlNRORNEWSQESQ-FEbtJLohyqWKkAfLeNcgcwCriFRiRA6wpfXyVzez2GTUME4iHbaVhBmzNc6CbhkWaq4wAmpEr1FNtzHuB84gZP76jNtf9uyQxbGv9Qumc9wRsEeumeF3LdgPgC03DhT
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lipoxygenase%3A+an+emerging+target+for+stroke+therapy&rft.jtitle=CNS+%26+neurological+disorders+drug+targets&rft.au=van+Leyen%2C+Klaus&rft.date=2013-03-01&rft.eissn=1996-3181&rft.volume=12&rft.issue=2&rft.spage=191&rft_id=info:doi/10.2174%2F18715273112119990053&rft_id=info%3Apmid%2F23394536&rft_id=info%3Apmid%2F23394536&rft.externalDocID=23394536